The study shows that patients with advanced lymph node metastasis (N2) and low ORP3 mRNA levels exhibit reduced survival probability compared to patients of the same group but high ORP3 mRNA levels. This evidence concerns the gene OSBPL3 and metastatic malignant neoplasm in the lymph nodes.